Last edition
News about Ingredients
The global demand for 2-Methylpiperazine is growing significantly due to its wide applicability in pharmaceutical formulations and specialty chemical development, according to a new study by Polaris Market Research.
Ingredients | 12/08/2025 | By Dineshwori | 245
India Clears 48 Projects Under PLI Scheme to Boost Domestic Production of Key Drug Ingredients
A total of 48 projects have been approved under the Production Linked Incentive (PLI) Scheme to boost domestic manufacturing of critical Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs) in India, according to the Ministry of Chemicals and Fertilizers.
Ingredients | 23/07/2025 | By Dineshwori | 714
Deuterated compounds play a vital role in cutting-edge sectors such as fiber optics, semiconductors, OLEDs, defense, and pharmaceuticals. Despite India's strong pharmaceutical manufacturing ecosystem, the country has so far relied on imports for high-purity deuterated chemicals due to a lack of scalable, domestic production technologies.
Ingredients | 09/07/2025 | By Darshana | 227
DGFT extends minimum import price on soda ash imports till December 2025 to ensure fair trade
Disodium carbonate, also known as soda ash, is used in the pharmaceutical industry as an excipient for various purposes, primarily for pH regulation and as a component in effervescent formulations. It acts as a buffer and pH adjuster in different pharmaceutical preparations, ensuring the stability and efficacy of the medication.
Ingredients | 03/07/2025 | By Darshana | 446
Roquette Introduces Innovative and High-Performance Coatings Platform
Featuring Tabshield® ready-to-use film coating systems and ReadiLYCOAT® plant-based ready-to-use coating systems, this platform provides groundbreaking solutions that speed up production while meeting the needs of a more diverse patient population.
Ingredients | 12/02/2025 | By Aishwarya | 343
The partnership will be formalised through the Biologics Pharma Innovation Programme Singapore
Ingredients | 08/12/2022 | By Sudeep Soparkar | 1147
Actimed Therapeutics receives S-pindolol patent in the UK
Actimed Therapeutics Ltd, a clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, announced the grant of a new UK Patent (GB 2593902 B) covering new salts of S-pindolol for use in the treatment or prevention of cachexia with an expiry date in 2040.
Ingredients | 05/05/2022 | By Sudeep Soparkar | 1309
Duchenne gene therapy trials resumed
Pfizer is set to resume its late-stage clinical trials of a treatment for Duchenne muscular dystrophy after stopping in December because of a clinical hold.
Ingredients | 02/05/2022 | By Sudeep Soparkar | 1020
The U.S. FDA has accepted Fennec Pharmaceuticals resubmitted new drug application (NDA) for Pedmark, a drug aimed at preventing hearing loss in children who receive platinum-based chemothera
Ingredients | 30/04/2022 | By Sudeep Soparkar | 1073
Schizophrenia and bi-polar drug gets FDA approval
The U.S. FDA has approved a new drug from BioXcel used to treat patients with schizophrenia or bipolar I or II disorder. BioXcel?s drug Igalmi was developed using the company?s artificial intelligence platform, marking a big step for the technology in the pharmaceutical industry, according to BioXcel.
Ingredients | 27/04/2022 | By Sudeep Soparkar | 798
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy